BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6391949)

  • 21. Prophylactic and sporontocidal treatment of chloroquine-resistant Plasmodium falciparum from Vietnam.
    Clyde DF; Miller RM; Music SI; McCarthy VC
    Am J Trop Med Hyg; 1971 Jan; 20(1):1-5. PubMed ID: 4936022
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent advances in malaria research: parasite biology, chemotherapy and host/parasite relationships.
    Trigg PI
    Ann Ist Super Sanita; 1985; 21(3):271-90. PubMed ID: 3914847
    [No Abstract]   [Full Text] [Related]  

  • 23. Malaria treatment and prevention. A review.
    Hall SA
    East Afr Med J; 1969 Oct; 46(10):553-63. PubMed ID: 4905723
    [No Abstract]   [Full Text] [Related]  

  • 24. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2003 Apr; 97(3):221-36. PubMed ID: 12803854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the chemotherapy of malaria.
    Pinder RM
    Prog Med Chem; 1971; 8(2):231-316. PubMed ID: 4947769
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of malaria.
    Hall AP
    Br Med J; 1976 Feb; 1(6005):323-8. PubMed ID: 764937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
    Davis TM
    Ann Pharmacother; 1998 Oct; 32(10):1104-6. PubMed ID: 9793605
    [No Abstract]   [Full Text] [Related]  

  • 28. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malaria prophylaxis in travellers: the current position.
    Stürchler D
    Experientia; 1984 Dec; 40(12):1357-62. PubMed ID: 6150865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies on treatment of cerebral malaria with artemether and mefloquine.
    Shwe T; Myint PT; Myint W; Htut Y; Soe L; Thwe M
    Trans R Soc Trop Med Hyg; 1989; 83(4):489. PubMed ID: 2694488
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 32. The problem of drug-resistant malaria.
    Clyde DF
    Am J Trop Med Hyg; 1972 Sep; 21(5):736-43. PubMed ID: 4561521
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical view of the biology of Plasmodia.
    Altstatt LB
    Ann Intern Med; 1969 Jan; 70(1):130-4. PubMed ID: 4884380
    [No Abstract]   [Full Text] [Related]  

  • 34. Malaria in Birmingham 1968-73.
    Ansdell VE; Boosey CM; Geddes AM; Morgan HV
    Br Med J; 1974 Apr; 2(5912):206-8. PubMed ID: 4598859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chemotherapy and prophylaxis of malaria.
    Saint-Yves IF
    Med J Aust; 1973 Dec; 2(23):1052-4. PubMed ID: 4590861
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol).
    Pearlman EJ; Doberstyn EB; Sudsok S; Thiemanun W; Kennedy RS; Canfield CJ
    Am J Trop Med Hyg; 1980 Nov; 29(6):1131-7. PubMed ID: 7004214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of new antimalarial drugs.
    Powell RD
    Am J Trop Med Hyg; 1972 Sep; 21(5):744-8. PubMed ID: 4561522
    [No Abstract]   [Full Text] [Related]  

  • 38. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
    J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of antimalarial regimens in Japan.
    Ohtomo H; Hioki A; Tanabe K; Nakabayashi T; Ishizaki T
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 May; 264(3-4):513-20. PubMed ID: 3310468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of drug-resistant malaria.
    Björkman A; Phillips-Howard PA
    Trans R Soc Trop Med Hyg; 1990; 84(2):177-80. PubMed ID: 2202097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.